According to a brand new research printed within the Journal of Affective Disorders, inhaled marijuana briefly mitigates signs of post-traumatic stress (PTS), together with nervousness and flashbacks. The research is titled Short and long-term results of hashish on signs of post-traumatic stress dysfunction.

For the research, researchers with the Washington State University and the University of Pennsylvania Perelman School of Medicine examined the use of marijuana in 404 medical hashish sufferers who self-identified as affected by post-traumatic stress. As reported by NORML, on common respondents “reported a 62 percent reduction in the severity of intrusive thoughts, a 51 percent reduction in flashbacks, a 67 percent reduction in irritability, and a 57 percent reduction in the severity of anxiety, from before to after inhaling cannabis.” Researchers reported no important variations in topics’ outcomes that have been attributable to particular varieties of hashish and or THC/CBD content material.

Authors reported that hashish’ results on PTS signs have been comparatively short-lived and that common use of marijuana over the research interval didn’t affect topics’ baseline symptom scores.

They concluded by stating that “Results from the present study indicate that acute cannabis intoxication provides temporary relief from intrusions, flashbacks, irritability, and anxiety in individuals self-identifying as having PTSD. However, baseline PTSD symptom ratings did not change over time and we detected evidence that people used higher doses to manage anxiety over time, which may be indicative of the development of tolerance to the drug.

“Collectively, these results indicate that cannabis may reduce PTSD symptoms in the short-term but may not be an effective long-term remedy for the disorder. Future research should examine specific cannabinoid preparations as monotherapy, as well as adjunct to conventional behavioral and pharmacological interventions, within well-powered placebo-controlled trials.”

The research’s full summary could be discovered beneath:

Background: Many people use hashish to handle signs of post-traumatic stress dysfunction (PTSD), and proof signifies that the endocannabinoid system represents a viable goal for treating these signs.

Method: Data from 404 medical hashish customers who self-identified as having PTSD have been obtained from Strainprint®, a medical hashish app that sufferers use to trace modifications in signs as a perform of completely different strains and doses of hashish throughout time. This pattern collectively used the app 11,797 occasions over 31 months to trace PTSD-related signs (intrusive ideas, flashbacks, irritability, and/or nervousness) instantly earlier than and after inhaling hashish. Latent change rating fashions have been used to look at modifications in symptom severity and predictors of these modifications (gender, dose, hashish constituents, time). Multilevel fashions have been used to discover long-term penalties of repeatedly utilizing hashish to handle these signs.

Results: All signs have been lowered by greater than 50% instantly after hashish use. Time predicted bigger decreases in intrusions and irritability, with later hashish use periods predicting better symptom reduction than earlier periods. Higher doses of hashish predicted bigger reductions in intrusions and nervousness, and dose used to deal with nervousness elevated over time. Baseline severity of all signs remained fixed throughout time.

Limitations: The pattern was self-selected, self-identified as having PTSD, and there was no placebo management group.

Conclusions: Cannabis supplies non permanent reduction from PTSD-related signs. However, it is probably not an efficient long-term treatment as baseline signs have been maintained over time and dose used for nervousness elevated over time, which is indicative of growth of tolerance.

Source link